ATXS
COM:ASTRIATX
Astria Therapeutics
- Stock
5.34
−6.32%
0.84
Last Close
4.50
07/04 20:00
Market Cap
301.36M
Beta: -
Volume Today
415.80K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -21.88M - | -32.63M 49.10% | -36.06M 10.51% | -27.36M 24.12% | -25.87M 5.46% | -26.29M 1.64% | -37.30M 41.86% | -194.91M 422.55% | -51.83M 73.41% | -72.89M 40.62% | |
depreciation and amortization | 248K - | 202K 18.55% | 395K 95.54% | 304K 23.04% | 119K 60.86% | 26K 78.15% | |||||
deferred income tax | 96K - | -4K 104.17% | -303K 7,475% | 23K 107.59% | |||||||
stock based compensation | 897K - | 1.66M 84.84% | 2.16M 30.28% | 2.01M 7.08% | 1.77M 11.76% | 1.51M 14.62% | 1.39M 8.07% | 3.36M 141.87% | 4.55M 35.46% | 6.31M 38.65% | |
change in working capital | 253K - | 684K 170.36% | 274K 59.94% | -1.93M 805.84% | 762K 139.40% | -1.87M 345.41% | 3.37M 280.05% | -3.31M 198.16% | 2.65M 180.09% | -2.41M 191.16% | |
accounts receivables | |||||||||||
inventory | |||||||||||
accounts payables | 481K - | 196K 59.25% | 77K 60.71% | -632K 920.78% | 662K 204.75% | -211K 131.87% | 347K 264.45% | -1.97M 666.28% | -766K 61.02% | 725K 194.65% | |
other working capital | -228K - | 488K 314.04% | 197K 59.63% | -1.30M 760.91% | 100K 107.68% | -1.66M 1,759% | 3.02M 282.04% | -1.34M 144.37% | 3.41M 354.70% | -3.14M 191.94% | |
other non cash items | 74K - | 293K 295.95% | 277K 5.46% | 155K 44.04% | 56K 63.87% | 33K 41.07% | 58K 75.76% | 164.70M 283,872.41% | 1.10M 99.33% | 545K 50.45% | |
net cash provided by operating activities | -20.41M - | -29.79M 45.96% | -32.86M 10.29% | -26.84M 18.33% | -23.46M 12.56% | -26.57M 13.23% | -32.48M 22.27% | -30.15M 7.18% | -43.53M 44.38% | -68.44M 57.23% | |
investments in property plant and equipment | -228K - | -421K 84.65% | -459K 9.03% | -57K 87.58% | 18K 131.58% | -12K 166.67% | -33K 175% | -21K 36.36% | -91K 333.33% | -25K 72.53% | |
acquisitions net | 45.54M - | -18K 100.04% | 4.07K 122.61% | -6.33K 255.60% | 6.47M 102,200.11% | 167.04K 97.42% | |||||
purchases of investments | -4.98M - | -45.54M - | -45.54M 0% | -70.36M 54.51% | -155.20M 120.56% | -62.78M 59.55% | -78M 24.25% | -396.06M 407.77% | -1.92B 385.89% | ||
sales maturities of investments | 4.98M - | 30.46M - | 14.91M 51.04% | 48.09M 222.54% | 151.13M 214.26% | 69.11M 54.27% | 59M 14.63% | 229.03M 288.18% | 2.06B 799.24% | ||
other investing activites | 52K - | 30K 42.31% | 369K 1,130% | -4.07K 101.10% | 6.33K 255.60% | -167.04K - | |||||
net cash used for investing activites | -228K - | -421K 84.65% | -15.49M 3,579.33% | 14.88M 196.08% | -21.91M 247.18% | -4.08M 81.36% | 6.30M 254.34% | -12.55M 299.29% | -167.13M 1,231.17% | 135.05M 180.81% | |
debt repayment | -833K - | -3.33M 300.12% | -3.33M 0% | -2.85M 14.55% | |||||||
common stock issued | 61.74M - | 11.99M 80.57% | 8.04M 33.00% | 47.14M 486.60% | 25.57M 45.76% | 40.83M 59.70% | 104.26M 155.36% | 144.64M 38.73% | 88.40M 38.88% | ||
common stock repurchased | |||||||||||
dividends paid | -24.44M - | ||||||||||
other financing activites | 4.83M - | 17.41M 260.26% | 503K 97.11% | 23K 95.43% | 4K 82.61% | 54K 1,250% | 31K 42.59% | 24.46M 78,803.23% | 84K 99.66% | ||
net cash used provided by financing activities | 4.83M - | 78.33M 1,520.31% | 9.16M 88.30% | 4.73M 48.43% | 44.30M 837.26% | 25.62M 42.16% | 40.86M 59.48% | 104.28M 155.22% | 144.72M 38.78% | 88.40M 38.92% | |
effect of forex changes on cash | |||||||||||
net change in cash | -15.81M - | 48.11M 404.39% | -39.18M 181.44% | -7.23M 81.56% | -1.07M 85.13% | -5.03M 368% | 14.68M 391.69% | 61.58M 319.61% | -65.94M 207.09% | 155.00M 335.07% | |
cash at beginning of period | 30.47M - | 14.67M 51.87% | 62.78M 328.01% | 23.60M 62.41% | 16.48M 30.15% | 15.41M 6.52% | 10.38M 32.65% | 25.05M 141.43% | 86.63M 245.81% | 20.69M 76.12% | |
cash at end of period | 14.67M - | 62.78M 328.01% | 23.60M 62.41% | 16.37M 30.63% | 15.41M 5.88% | 10.38M 32.65% | 25.05M 141.43% | 86.63M 245.81% | 20.69M 76.12% | 175.69M 749.25% | |
operating cash flow | -20.41M - | -29.79M 45.96% | -32.86M 10.29% | -26.84M 18.33% | -23.46M 12.56% | -26.57M 13.23% | -32.48M 22.27% | -30.15M 7.18% | -43.53M 44.38% | -68.44M 57.23% | |
capital expenditure | -228K - | -421K 84.65% | -459K 9.03% | -57K 87.58% | 18K 131.58% | -12K 166.67% | -33K 175% | -21K 36.36% | -91K 333.33% | -25K 72.53% | |
free cash flow | -20.64M - | -30.21M 46.39% | -33.32M 10.27% | -26.89M 19.28% | -23.45M 12.81% | -26.58M 13.37% | -32.52M 22.34% | -30.17M 7.21% | -43.62M 44.58% | -68.47M 56.95% |
All numbers in USD (except ratios and percentages)